Tag: Nature Identical™

July 9, 2019

PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System

PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System
June 21, 2019

PreveCeutical Announces Appointment of New Directors

PreveCeutical Medical Inc. (CSE:PREV), is pleased to announce the appointments of Keith Anderson and Mark Lotz to the board of...
June 17, 2019

PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide positive results from...
June 3, 2019

PreveCeutical Secures $300,000 Loan and Resignation of a Director

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H)(the "Company" or "PreveCeutical") announces that it has received a loan in the aggregate amount...
May 21, 2019

PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), announces that the Company's research team at the University of...
April 17, 2019

PreveCeutical Partnership Leads to Two New Patent Filings

PreveCeutical Medical Inc. (CSE:PREV) (OTCQB PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that the Company's research collaboration with UniQuest and The University of...
April 15, 2019

PreveCeutical Files Application to Human Ethics Committee to Acquire Human Tissue for the Final Phase of the Sol-Gel Program

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), announces the Company's research team at the University of Queensland...